Skip to main content

Table 3 Time to Revision Surgery in Days

From: Readmissions, revisions, and mortality after treatment for proximal humeral fractures in three large states

  Initial Treatment  
Non-Operative ORIF Arthroplasty p-value*
California:
 ORIF 90.7 ± 284.3; 1–2214 358.2 ± 527.5; 4–2209 482.9 ± 331.7; 14–1143 < 0.0001
 Arthroplasty
Mean ± SD; range 		182.7 ± 375.9; 1–2279 317.1 ± 370.2; 9–1735 599.1 ± 487.3; 1–1847 < 0.0001
Florida:
 ORIF 139.5 ± 436.0; 1–3476 623.4 ± 739.2; 5–2938 1002.8 ± 791.5; 33–2616 < 0.0001
 Arthroplasty
Mean ± SD; range 		192.9 ± 455.2; 1–3549 378.6 ± 523.0; 9–2392 588.2 ± 628.9; 9–3354 < 0.0001
New York:
 ORIF 89.8 ± 275.5; 1–2199 356.5 ± 491.8; 2–1827 606.0 ± 624.3; 23–1668 < 0.0001
 Arthroplasty
Mean ± SD; range 		145.6 ± 341.6; 1–2330 294.5 ± 345.3; 6–1662 568.0 ± 533.1; 12–1551 < 0.0001
  1. ORIF open reduction and internal fixation
  2. SD standard deviation
  3. * p-values of non-operative vs. ORIF vs. arthroplasty as treatment
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us